Your Story

PlasmaGen raises Rs 225 Cr in new equity round

Bengaluru-headquartered biopharma company PlasmaGen Biosciences has raised Rs 225 crore from UK-based Artian Investments, public markets investor Ashish Kacholia, pharma industry entrepreneurs ...
Pharmabiz

Plasmagen taps into Indian biopharma market with CSL’s Haemocomplettan P to prevent massive bleeding during surgery

Plasmagen Biosciences specializing exclusively in plasma protein and speciality care therapy, has recently announced the launch of Haemocomplettan P (Human Fibrinogen Concenrate), manufactured by CSL ...
Webindia 123

PlasmaGen Biosciences Opens New, State-of-the-Art Manufacturing Facility for Blood Plasma Products in Kolar, Bengaluru

Bengaluru (Karnataka) [India], May 30: PlasmaGen Biosciences ('PlasmaGen'), a biopharmaceutical company focused on blood plasma-derived pharmaceutical products for India and emerging markets, recently ...
VCCircle

PlasmaGen BioSciences raises $25 mn from Eight Roads Ventures, F-Prime

Biopharmaceutical company PlasmaGen BioSciences Pvt. Ltd said on Tuesday it has raised $25 million (Rs 160.4 crore) from investors led by private equity firm Eight Roads Ventures India. US-based ...
Webindia 123

PlasmaGen Biosciences completes INR 225 crores equity financing to drive growth from its state-of-the-art manufacturing facility for plasma products

Bengaluru (Karnataka) [India], December 15: PlasmaGen Biosciences ('PlasmaGen'), a biopharmaceutical company focused on blood plasma-derived pharmaceutical products for India and emerging markets, ...
Your Story

PlasmaGen raises $25M from Eight Roads Ventures and F-Prime Capital Partners

On Tuesday, Bengaluru-based biopharmaceutical company PlasmaGen BioSciences Private Limited announced having raised an investment of close to $25 million in a round led by Eight Roads Ventures India ...
health.economictimes.indiatimes

Plasmagen Biosciences launches blood clotting therapy to overcome haemorrhagic cases

Mumbai: Bengaluru based Plasmagen Biosciences Private Limited, launched Haemocomplettan P (Human Fibrinogen Concentrate), a therapy to stop clotting of blood during cardiac and liver transplant ...
The Hindu

Plasmagen Biosciences introduces CSL’s Haemocomplettan P in India

Plasmagen Biosciences Private Ltd., specialising in Plasma Protein and Speciality Care Therapy, has announced the introduction of Haemocomplettan P (Human Fibrinogen Concenrate), manufactured by CSL ...
Indiatimes

PlasmaGen BioSciences raised $25 million funding

Biopharmaceutical company PlasmaGen BioSciences has raised $25 million funding led by Eight Roads Ventures with participation from US-based F-Prime Capital Partners and the founders. PlasmaGen was ...